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Introduction. We determined derivatives of reactive oxygen metabolites (dROMs) as an index of oxidative stress level (oxidant
capacity) and biochemical antioxidant potential (BAP) as an index of antioxidant capacity in rats exposed to diﬀerent oxygen
concentrations.Methods. MaleWistar rats were exposed to 14.4%, 20.9%, 35.5%, 39.8%, 62.5%, and 82.2% oxygen at 1 atmosphere
absolute for 24 h. Serum levels of dROMs and BAP were examined by using a free radical and antioxidant potential determination
device. The morphological characteristics of red blood cells were examined by phase contrast microscopy. Results. There were no
diﬀerences in the levels of dROMs in rats exposed to 14.4%, 20.9%, and 35.5% oxygen. However, the levels of dROMs increased
in the rats exposed to 39.8% and 62.5% oxygen. The levels of dROMs were the highest in the rats exposed to 82.2% oxygen.
There were no diﬀerences in the levels of BAP with respect to the oxygen concentration. Morphological changes in the red blood
cells induced by oxidative attack from reactive oxygen species were observed in the rats exposed to 39.8%, 62.5%, and 82.2%
oxygen. Conclusion. Our results suggest that exposure to oxygen concentrations higher than 40% for 24 h induces excessive levels
of oxidative stress in rats.
1. Introduction
Supplemental oxygen is used in treatment and as a coun-
termeasure for acute and chronic diseases. When pilots of
unpressurized aircrafts fly to areas at high altitudes, when
climbers ascend high-altitude peaks and outpace their ability
to acclimatize, or when divers inhaling compressed air return
to the surface, the external pressure on the body decreases
and the dissolved inert gases come out of solution in the
form of bubbles in the body on depressurization [1, 2].
The resulting decompression sicknesses and air embolisms
are initially treated by inhalation of oxygen-enriched air or
exposure to mild hyperbaric oxygen at 1.25 atmospheres
absolute (ATA) until hyperbaric oxygen therapy (100% oxy-
gen delivered at 2-3 ATA) is administered [3–6]. Hypoxic or
breathless patients with chronically obstructive pulmonary
disease (COPD), who have low levels of oxygen in their
blood, require oxygen at concentrations greater than that in
room air to achieve arterial oxygen saturations between 88%
and 92% [7].
Oxygen therapy with or without pressure is associated
with the risk of oxygen toxicity and excessive oxidative
stress. Oxidative stress plays as key role in the pathogenesis
of many diseases and their complications; the generation
of free radicals and increased levels of oxidative stress
are associated with atherosclerosis, cataract, retinopathy,
myocardial infarction, hypertension, diabetes, renal failure,
and uremia [8–10]. However, there are no data available
on changes in the oxidative stress level and antioxidant
capacity after exposure to diﬀerent concentrations of oxygen.
The analytical measurement of oxidative stress markers
has been diﬃcult because of the short half-life and high
reactivity of the majority of reactive oxygen species and the
applicability of measurement methods [11]. Blood samples
are the appropriate biological materials for assessing the
status of oxidants and antioxidants. A unique system for the
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evaluation of oxidative stress levels and antioxidant capacity
in the blood has been developed [12]. This evaluation
approach is based on the free radical analytical system that
mainly analyzes lipid hydroperoxides, which are relatively
stable in the blood. This system has been used for both
animal and human sera, which confirms its applicability
[13–15].
In this study, we examined the derivatives of reactive
oxygen metabolites (dROMs) as an index of oxidative stress
levels (oxidant capacity) and the biochemical antioxidant
potential (BAP) as an index of antioxidant capacity in rats
exposed to diﬀerent concentrations of oxygenat 1 ATA for
24 h.
2. Materials and Methods
2.1. Experimental Animals. All experimental and animal
care procedures were performed in accordance with the
guidelines stated in the Guide for the Care and Use of
Laboratory Animals issued by the Institutional Animal
Experiment Committee of Kyoto University (Kyoto, Japan).
2.2. Exposure to Diﬀerent Concentrations of Oxygen. Ten-
week-old male Wistar rats weighing between 200 g and 226 g
were divided into 6 groups (n = 5 for each group). The
individual groups were exposed to air containing low or high
concentration of oxygen in a chamber (75 × 130 × 85 cm)
at 1 ATA for 24 h by using a low-oxygen inhaler (Terucom
Corp., Yokohama, Japan) or an oxygen concentrator (Ikiken
Corp., Sayama, Japan), respectively. When the air chamber
contained less or more than 20.9% oxygen, air with 2 diﬀer-
ent concentrations of oxygen from 2 tubes was transported
to the aspirator: one tube contained normal air (20.9%
oxygen) and the other tube had air containing 13% or 84%
oxygen, which was procured from the low-oxygen inhaler
or the oxygen concentrator, respectively. Then, the aspirator
pumped mixed air into the chamber at the rate of 1 L/min.
The low or high oxygen concentration in the chamber was
adjusted by separately regulating the air flow from these 2
tubes. Normal air was transported by only 1 tube, while the
air containing 20.9% oxygen was retained in the chamber.
The oxygen concentration in the chamber was determined
by using an oxygen monitor (Max O2+AE; Maxtec Inc., UT,
USA) attached to the chamber. The rats were maintained in
individual, uniformly sized standard cages (30× 40× 20 cm)
in the chamber. The room was maintained at 22 ± 2◦C with
45%–55% relative humidity. Food and water were provided
ad libitum.
2.3. Measurements of dROMs and BAP. The levels of dROMs
and BAP were determined after the rats were exposed to
diﬀerent concentrations of oxygen. Blood samples were
obtained from the tail of fully conscious rats and evaluated
photometrically. A free radical and antioxidant potential
determination device (Free Radical Analytical System 4;
Health & Diagnostics, Grosseto, Italy) was used to automati-
cally measure the levels of dROMs and BAP.
The dROMs are used as an index to determine the
level of oxidative stress (oxidant capacity) by measuring
the amount of organic hydroperoxide (ROOH) converted
into radicals that oxidize N,N-diethyl-p-phenylenediamine
[12, 16]. The levels of dROMs were expressed in Carr units
(1U·Carr corresponds to 0.08mg hydroperoxide/100mL
H2O2). The BAP is used as an index to determine the
biological antioxidant capacity and is measured on the
basis of the capacity of the plasma sample to reduce ferric
ions to ferrous ions. After blood samples were obtained,
the rats were killed by intraperitoneal overdose of sodium
pentobarbital.
2.4. Red Blood Cell Morphology. Using blood samples, the
morphological profiles of red blood cells were observed
by phase contrast microscopy (Nikon 80iF-PH-15; Tokyo,
Japan).
2.5. Statistics. Means and standard deviations were calcu-
lated from the individual values by using standard proce-
dures. One-way analysis of variance (ANOVA) was used to
evaluate the mean diﬀerences among the 6 groups. When
ANOVA analyses revealed significant diﬀerences in mean
values, the groups were further compared using Scheﬀe´’s
post hoc tests. A probability level of 0.05 was considered
significant.
3. Results
The levels of dROMs in rats exposed to 39.8% and 62.5%
oxygen were higher than those in the rats exposed to 14.4%,
20.9%, and 35.5% oxygen (Figure 1(a)). The level of dROMs
in the rats exposed to 82.2% oxygen was the highest among
the 6 groups. There were no diﬀerences in the levels of BAP
among the 6 groups (Figure 1(b)). Morphological changes in
red blood cells were observed in the rats exposed to 39.8%,
62.5%, and 82.2% oxygen (Figure 2).
4. Discussion
4.1. Exposure to Low Concentration of Oxygen. Acclimatiza-
tion at high altitude results in changes in the respiratory,
cardiovascular, and hematologic systems, which enhance
oxygen delivery to the cells and tissues [17]. Decompression
sickness occurs between initial hypoxic conditions and the
onset of acclimatization, and the incidence and severity
of the sickness depend on the rate of ascent, the alti-
tude attained, and physiological susceptibility of individuals
[5].
There is little data available regarding the oxidative stress
level under low concentrations of oxygen. In this study, we
examined the oxidative stress levels in rats exposed to low
concentrations of oxygen. In rats exposed to 14.4% oxygen
for 24 h, which is equivalent to the oxygen concentration at
3500m/11500 feet altitude, no change was observed in the
oxidative stress level (Figure 1(a)). Therefore, we conclude
that low concentrations of oxygen do not induce excessive
oxidative stress.






































Figure 1: Levels of derivatives of reactive oxygen metabolites (a)
and biochemical antioxidant potential (b) of rats after exposure to
diﬀerent concentrations of oxygen for 24 h. Values are expressed
as the mean and standard deviation (n = 5 for each group). Five
dots on the right side of the bar are the individual values of rats
in each group. dROMs: derivatives of reactive oxygen metabolites;
BAP: biochemical antioxidant potential. ∗P < 0.05 compared with
values of 14.4%, 20.9%, and 35.5% oxygen; ∗∗P < 0.05 compared
with values of 14.4%, 20.9%, 35.5%, 39.8%, and 62.5% oxygen.
4.2. Exposure to High Concentration of Oxygen. Hyperbaric
oxygen at 2-3 ATA with 100% oxygen induces acute changes,
such as increased blood pressure and further reduction in
heart rate [18], and causes chronic diseases like cataract
formation [19–22]; hyperbaric oxygen is generally safe when
pressures do not exceed 3 ATA and the length of treatment is
less than 120min [23, 24]. However, hyperbaric oxygen has
been reported to increase the levels of reactive oxygen species
[25–27].
Patients with COPD inhale high concentrations of oxy-
gen, generally up to 50% oxygen (fraction of inspired oxygen,
FIO2) when the partial pressure of oxygen in the arterial
blood (PaO2) is below 55mmHg; these patients occasionally
exhibit voluntary respiration failure, consciousness distur-
bance, and atelectasis when inhaling high concentrations of
oxygen.
Oxygen therapy with or without pressure might induce
excessive levels of oxidative stress. Excessive levels of oxida-
tive stress are associated with many diseases, including
atherosclerosis, cataract, retinopathy, myocardial infarction,
hypertension, renal failure, and uremia [8–10]. In this study,
we examined the oxidative stress levels in rats exposed to high
concentrations of oxygen.
No change in the oxidative stress level was observed
at 35.5% oxygen for 24 h (Figure 1(a)). We previously
examined the eﬀects of mild hyperbaric oxygen at 1.25 ATA
with 36% oxygen on the neuromuscular system, including
spinal motoneurons and their innervating muscle fibers
[28, 29], type 2 diabetes [30–33], hypertension [34], type II
collagen-induced arthritis [35], age-related decline in muscle
oxidative capacity [36], and diabetes-induced cataracts [37]
in mice and rats. Therefore, the data observed in this study
suggest that mild hyperbaric oxygen at 1.25 ATA with 36%
oxygen is eﬀective for the inhibition and improvement
of many metabolic diseases [28–37], without producing
excessive levels of oxidative stress.
In contrast, 39.8% and 62.5% oxygen for 24 h induced
excessive levels of oxidative stress, and the level of dROMs
was the highest at 82.2% oxygen (Figure 1(a)). Oxidative
stress level increases when the production of reactive oxygen
species is markedly greater than the intrinsic antioxidant
defenses. Patients with COPD inhale high concentrations of
oxygen, and the possibility of accumulating excessive levels
of oxidative stress will be greater when the inhaled oxygen
concentration (FIO2) is high. Therefore, we conclude that
exposure to 40% oxygen for 24 h is a threshold for inducing
an excessive level of oxidative stress.
In our previous study [15], we observed that obese rats
with metabolic syndrome accompanied by insulin resistance,
impaired glucose metabolism, and dyslipidemia had lower
levels of BAP than normal Wistar rats. In addition, we
observed that mild hyperbaric exposure at 1.25 ATA with
36% oxygen improves the levels of BAP in rats with hyperten-
sion [34]. These studies [15, 34] suggest that changes in the
levels of BAP are reflected as an index of antioxidant capacity.
In this study, we expected that exposure to higher concentra-
tions of oxygen would decrease the levels of BAP compared
with exposure to 20.9% oxygen because the levels of dROMs
were increased by exposure to 39.8%, 62.5%, and 82.2%
oxygen (Figure 1(a)). However, there was no diﬀerence in
the levels of BAP among diﬀerent concentrations of oxygen
(Figure 1(b)). These results suggest that the antioxidant
capacity is not aﬀected by both low and high concentrations
of oxygen, and thus, the antioxidant capacity did not change,
at least after 24 h. However, we did not examine antioxidant
enzyme levels of rats exposed to diﬀerent concentrations






Figure 2: Morphological features of red blood cells after 24 h of exposure to diﬀerent concentrations of oxygen: (a) 14.4%, (b) 20.9%, (c)
35.5%, (d) 39.8%, (e) 62.5%, and (f) 82.2%. RBC: red blood cell; WBC: white blood cell. Scale bar is 10 µm.
of oxygen. In our subsequent study, we plan to examine
the levels of BAP and antioxidant enzymes, for example,
superoxide dismutase, catalase, and glutathione peroxidase,
in rats exposed to diﬀerent concentrations of oxygen for
more than 24 h.
Transformed red blood cells, which were induced by
oxidative attack from reactive oxygen species, were observed
by exposure to 39.8%, 62.5%, and 82.2% oxygen (Figure 2);
these findings are consistent with the increased levels of
dROMs at these oxygen concentrations (Figure 1(a)). There-
fore, we conclude that morphological changes in the red
blood cells are linked to increased levels of oxidative stress.
5. Conclusion
Exposure to oxygen concentrations higher than 40% for 24 h
induces excessive levels of oxidative stress.
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